(Q72103400)
Statements
Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors (English)
R J Motzer
M Mazumdar
S C Gulati
D F Bajorin
P Lyn
V Vlamis
1 November 1993